adr_usa_0461|BCYC|Short Name|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
adr_usa_0461|BCYC|Long Name|Bicycle Therapeutics PLC Total Current Assets (Quarterly) (USD)|Bicycle Therapeutics PLC Cash and Short Term Investments (Quarterly) (USD)|Bicycle Therapeutics PLC Inventories (Quarterly) (USD)|Bicycle Therapeutics PLC Net PP&E (Quarterly) (USD)|Bicycle Therapeutics PLC Goodwill and Intangibles (Quarterly) (USD)|Bicycle Therapeutics PLC Total Liabilities (Quarterly) (USD)|Bicycle Therapeutics PLC Total Current Liabilities (Quarterly) (USD)|Bicycle Therapeutics PLC Total Long Term Liabilities (Quarterly) (USD)|Bicycle Therapeutics PLC Total Deposits (Quarterly) (USD)|Bicycle Therapeutics PLC Book Value (Quarterly) (USD)|Bicycle Therapeutics PLC Retained Earnings (Quarterly) (USD)|Bicycle Therapeutics PLC Treasury Stock (Quarterly) (USD)|Bicycle Therapeutics PLC EV to Revenues|Bicycle Therapeutics PLC EV to Earnings|Bicycle Therapeutics PLC EV to Free Cash Flow|Bicycle Therapeutics PLC EV to Assets (Quarterly)|Bicycle Therapeutics PLC PS Ratio|Bicycle Therapeutics PLC PE Ratio|Bicycle Therapeutics PLC Price to Book Value|Bicycle Therapeutics PLC PEG Ratio|Bicycle Therapeutics PLC Debt to Equity Ratio|Bicycle Therapeutics PLC Dividend Yield|Bicycle Therapeutics PLC Shareholder Yield (TTM)|Bicycle Therapeutics PLC Percent of Shares Outstanding Short|Bicycle Therapeutics PLC Total Receivables (Quarterly) (USD)|Bicycle Therapeutics PLC Total Payables (Quarterly) (USD)|Bicycle Therapeutics PLC Total Capital Stock (Quarterly) (USD)|Bicycle Therapeutics PLC Return on Invested Capital|Bicycle Therapeutics PLC Quality Ratio Score|Bicycle Therapeutics PLC Momentum Score|Bicycle Therapeutics PLC Beta (1Y)|Bicycle Therapeutics PLC Sustainable Growth Rate (TTM)|Bicycle Therapeutics PLC Institutional Investor Ownership Percentage|Bicycle Therapeutics PLC Average Diluted Shares Outstanding (Quarterly)|Bicycle Therapeutics PLC Total Employees (Annual)|Bicycle Therapeutics PLC EPS Diluted (Quarterly) (USD)|Bicycle Therapeutics PLC Dividend Per Share (Quarterly) (USD)|Bicycle Therapeutics PLC Revenue (Quarterly) (USD)|Bicycle Therapeutics PLC Gross Profit (Quarterly) (USD)|Bicycle Therapeutics PLC SG&A Expense (Quarterly) (USD)|Bicycle Therapeutics PLC Pre-Tax Income (Quarterly) (USD)|Bicycle Therapeutics PLC Net Income (Quarterly) (USD)|Bicycle Therapeutics PLC Net Interest Income (Quarterly) (USD)|Bicycle Therapeutics PLC Price (USD)|Bicycle Therapeutics PLC Total Return Price (USD)|Bicycle Therapeutics PLC Enterprise Value (USD)|Bicycle Therapeutics PLC 30-Day Average Daily Volume|Bicycle Therapeutics PLC 1 Year Price Returns (Daily)||
adr_usa_0461|BCYC|Unit|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
adr_usa_0461|BCYC|201803||||||||||||||||||||||||||||||||||13.2934||-0.1906||2.808||1.988|-2.93|-2.534|-0.003|||||||
adr_usa_0461|BCYC|201806||||||||||||||||||||||||||||||||||13.2934||-0.3745||1.661||1.702|-4.979|-4.979|0.052|||||||
adr_usa_0461|BCYC|201809||||||||||||||||||||||||||||||||||13.2934||-0.5786||1.61||2.325|-7.692|-7.692|0.026|||||||
adr_usa_0461|BCYC|201812|76.769|63.38||1.818||151.452|8.929|142.523||-69.826|-69.942||||||||||0||||11.313|1.902|0.01|||||||13.2934||-0.4996||1.057||2.106|-6.641|-6.641|0.094|||||||
adr_usa_0461|BCYC|201903|69.926|59.371||4.389||20.886|8.419|12.467||56.915|-76.445||||||||||0||||8.331|2.249|0.173|||||||17.6964||-0.3675||6.384||3.402|-6.423|-6.503|0.064||||||12|12
adr_usa_0461|BCYC|201906|120.452|108.536||4.388||21.687|9.44|12.247||104.559|-86.662||6.7668|-2.304|-2.5793|0.5667|12.2697||||0|0|-31.759|0.2046|9.895|2.838|0.226|-101.6487||||-101.6487||7.2981|62|-1.4||1.522||2.973|-10.082|-10.217|0.09|10.06|10.06|71.545|||9.9|9.9
adr_usa_0461|BCYC|201909|110.25|95.954||4.329||20.735|8.835|11.9||95.325|-96.144||11.2728|-3.2872|-3.1639|0.9302|16.7065||2.1391||0|0|-27.6494|0.197|10.76|2.003|0.226|-70.2626||||-70.2626|76.2047|17.901|67|-0.53||0.614||4.789|-9.813|-9.482|0.44|11.39|11.39|107.96|30335.8667||11.08|11.08
adr_usa_0461|BCYC|201912|104.146|92.117||4.348||16.996|8.821|8.175||93.198|-100.55||5.6201|-2.5341|-2.5711|0.7039|10.4012||1.8206|-0.0673|0|0|-33.5672|0.0666|7.145|1.95|0.227|-54.6238||||-54.6238|73.0506|17.9937|72|-0.25||5.281||3.396|-4.544|-4.406|0.22|9.43|9.43|77.5636|58985.3667||9.82|9.82
adr_usa_0461|BCYC|202003|123.39|109.637||4.018||47.469|16.197|31.272||81.813|-111.874||15.9471|-3.8467|-36.764|1.0542|24.4341||3.0059|-0.0893|0|0|-23.1607|0.1267|9.505|4.441|0.227|-41.0238||||-41.0238|74.5569|17.9979|78|-0.63||1.129||4.998|-11.431|-11.324|0.212|13.65|13.65|136.2841|35622.9||13.98|13.98
adr_usa_0461|BCYC|202006|112.531|96.91||3.8||47.576|16.978|30.598||71.026|-123.989||21.8561|-5.0326|-22.6712|1.5839|32.9498||4.0093|-0.1056|0|0|0.2848|0.5569|11.303|3.338|0.228|-41.8538||9|-0.3271|-41.8538|77.0671|18.0778|77|-0.67||1.571||6.196|-12.212|-12.115|0.371|15.74|15.74|187.8534|31614.2|56.4612|15.3|15.3
adr_usa_0461|BCYC|202009|||||||||||||31.4669||-32.6403||39.8789||5.1723|||0||1.1993||||||10|-0.3808||50.835|||||||||||19.05|19.05|270.4578|93074.5333|67.252|19.5|19.5